An “Omics” view of drug development
- 1 June 2004
- journal article
- review article
- Published by Wiley in Drug Development Research
- Vol. 62 (2) , 81-85
- https://doi.org/10.1002/ddr.10370
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- A Statistical Approach to Scanning the Biomedical Literature for Pharmacogenetics KnowledgeJournal of the American Medical Informatics Association, 2004
- PharmGKB: the pharmacogenetics and pharmacogenomics knowledge baseThe Pharmacogenomics Journal, 2004
- The International HapMap ProjectNature, 2003
- The Ile164 β2-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to GsEuropean Journal of Pharmacology, 2001
- Complex promoter and coding region β 2 -adrenergic receptor haplotypes alter receptor expression and predict in vivo responsivenessProceedings of the National Academy of Sciences, 2000